Last quarters product sales revenues were 1.3 million.
Analyst are looking for 2.63 million this quarter.
While a miss seems to be expected I think we need to at least keep the 1.3 million in product sales going, same as last quarter.
So here is what I am looking for.

Any product sales revenue number with a two in front of it will be viewed as positive. Even if we miss the 2.63 million est.

1.3 to 2.0 million will see a sell-off but doest fill the gap on the chart that has been talked about.

Below last quarters 1.3 million in revenues and we may get hit hard and the possibility of the chart gap fill exist.

What I will be listening for in the CC are money issues, reduction in 2009 forcast, partnerships and the possibility of non dilutive capital, FDA progress.

Comments welcome.